A new bioassay for glucagon

British Journal of Pharmacology
G GagnonF Rioux

Abstract

1 The relaxant action of glucagon has been studied in strips of rabbit renal arteries partially contracted by a low concentration (1 ng/ml) of noradrenaline.2 The preparation was relaxed in a dose-dependent manner by concentrations of glucagon varying between 25 ng/ml and 420 ng/ml.3 The relaxant effect of glucagon (0.1 mug/ml approximately ED(60)) on this preparation was not affected by propranolol (5.0 mug/ml), cimetidine (10 mug/ml), diphenhydramine (10 mug/ml), indomethacin (5.0 mug/ml), phentolamine (1.2 mug/ml), atropine (10 mug/ml) and 8-Leu-AT(II) (1.0 mug/ml) but was slightly potentiated by Des-Arg(9) Leu-OMe(8)-Bk (25 mug/ml) and indomethacin (50 mug/ml).4 The dose-response curve to glucagon remained parallel in the presence of papaverine (2.5 mug/ml) but was shifted to the left by a factor of 2.5 to 2.8. Theophylline (250 mug/ml) also potentiated the vascular relaxation induced by glucagon.5 Insulin (10 mug/ml) did not influence the relaxant effect of glucagon.6 The removal of the N-terminal amino acid (His) of glucagon reduced by 89% the biological activity of this fragment on the vascular preparation. The removal of the C-terminal amino acids Met-27, Asn-28 and Thr-29 of glucagon resulted in a fragment which was in...Continue Reading

References

Nov 1, 1976·Metabolism: Clinical and Experimental·V J HrubyM Rodbell
Aug 1, 1978·Canadian Journal of Physiology and Pharmacology·A BérubéD Regoli
Nov 1, 1976·Metabolism: Clinical and Experimental·L G HedingH Jacobsen
Jan 21, 1977·European Journal of Pharmacology·J UedaY Abe
Aug 1, 1977·Canadian Journal of Physiology and Pharmacology·D RegoliW K Park
Nov 1, 1976·Metabolism: Clinical and Experimental·W W Bromer
Feb 1, 1969·Circulation Research·G S Levey, S E Epstein
Dec 30, 1971·Annals of the New York Academy of Sciences·L TrinerS H Ngai
Feb 1, 1974·Canadian Journal of Biochemistry·W K ParkD Regoli
Jun 1, 1968·Circulation Research·B R Lucchesi
Jul 1, 1969·Biochemistry·M Vaughan, F Murad
Apr 1, 1970·British Journal of Pharmacology·N J Gilore, J R Vane
Apr 5, 1973·The New England Journal of Medicine·D M RochaR H Unger
Nov 1, 1972·Clinics in Endocrinology and Metabolism·V Marks
Jul 2, 1973·Biochemical and Biophysical Research Communications·W W BromerJ M Patterson
Jul 1, 1972·The Journal of Clinical Endocrinology and Metabolism·I BöttgerR H Unger
May 1, 1971·Proceedings of the National Academy of Sciences of the United States of America·M RodbellF Sundby
May 1, 1967·The American Journal of Medicine·R WalterI L Schwartz
Nov 1, 1969·Diabetes·E Aguilar-ParadaR H Unger
Apr 1, 1970·British Journal of Pharmacology·G Ross
Sep 1, 1957·British Journal of Pharmacology and Chemotherapy·J R VANE
Mar 1, 1959·British Journal of Pharmacology and Chemotherapy·E W HORTON
Jul 1, 1961·The Journal of Clinical Investigation·R H UNGERL L MADISON
Oct 1, 1964·British Journal of Pharmacology and Chemotherapy·D REGOLI, J R VANE
Jun 1, 1950·British Journal of Pharmacology and Chemotherapy·M MANN, G B WEST

❮ Previous
Next ❯

Citations

Jun 17, 1983·European Journal of Pharmacology·K Damm JørgensenB Diamant
Jun 5, 2012·Pharmacology & Therapeutics·Young Min ChoTimothy J Kieffer
Oct 1, 1980·British Journal of Pharmacology·G GagnonF Rioux
Jul 1, 1980·British Journal of Pharmacology·G GagnonF Rioux
Jun 1, 1981·Hoppe-Seyler's Zeitschrift für physiologische Chemie·E K FrandsenA Vølund

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.